Given the pHi regulatory activity demonstrated in previous studies [10, 26], SLC4A11 naturally owns a strong cellular buffering capacity that enables the highly glycolytic cancer cells to remove lactic acid rapidly. The gene discussed is SLC4A11; the disease is cancer.